Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-6 of  6 results for ""Apolipoprotein C-I""

Your Filters

Publication : diabetes care
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Relationship of Plasma Apolipoprotein C-I Truncation With Risk of Diabetes in the Multi-Ethnic Study of Atherosclerosis and the Actos Now for the Prevention of Diabetes Study.

  • Authors : Koska J; Phoenix VA Health Care System, Phoenix, AZ.; Hu Y

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/blood ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Apolipoprotein C-I*/Apolipoprotein C-I*/Apolipoprotein C-I*/blood

  • Source: Diabetes care [Diabetes Care] 2024 Dec 01; Vol. 47 (12), pp. 2214-2222.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glycation of apolipoprotein C1 impairs its CETP inhibitory property: pathophysiological relevance in patients with type 1 and type 2 diabetes.

Subjects: Apolipoprotein C-I/Apolipoprotein C-I/Apolipoprotein C-I/*metabolism ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*metabolism

  • Source: Diabetes care [Diabetes Care] 2014 Apr; Vol. 37 (4), pp. 1148-56. Date of Electronic Publication: 2014 Feb 26.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome.

  • Authors : van der Ham RL; Section of Vascular Medicine, Department of Endocrinology and Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands. .; Alizadeh Dehnavi R

Subjects: Adipose Tissue/Adipose Tissue/Adipose Tissue/*pathology ; Apolipoprotein C-I/Apolipoprotein C-I/Apolipoprotein C-I/*blood ; Apolipoprotein C-III/Apolipoprotein C-III/Apolipoprotein C-III/*blood

  • Source: Diabetes care [Diabetes Care] 2009 Jan; Vol. 32 (1), pp. 184-6. Date of Electronic Publication: 2008 Oct 03.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of hepatic lipase -514C->T polymorphism and its interactions with apolipoprotein C3 -482C->T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in chinese type 2 diabetic patients.

  • Authors : Baum L; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong.; Ng MC

Subjects: Polymorphism, Single Nucleotide*; Apolipoproteins C/Apolipoproteins C/Apolipoproteins C/*genetics ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*genetics

  • Source: Diabetes care [Diabetes Care] 2005 Jul; Vol. 28 (7), pp. 1704-9.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.

Subjects: Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*therapeutic use ; Apolipoproteins B/Apolipoproteins B/Apolipoproteins B/*blood ; Apolipoproteins C/Apolipoproteins C/Apolipoproteins C/*blood

  • Source: Diabetes care [Diabetes Care] 2004 Jun; Vol. 27 (6), pp. 1358-64.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Report

Differential levels of gamma-glutamyl transferase activity and apolipoprotein CIII in men on either statin or fibrate therapy.

Subjects: Apolipoproteins C/Apolipoproteins C/Apolipoproteins C/*blood ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use ; gamma-Glutamyltransferase/gamma-Glutamyltransferase/gamma-Glutamyltransferase/*blood

  • Source: Diabetes care [Diabetes Care] 2003 May; Vol. 26 (5), pp. 1652-3.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
  • 1-6 of  6 results for ""Apolipoprotein C-I""